Redeye provides its initial view on Kontigo Care’s Q1 2025 results, which came in slightly below expectations on both sales and MRR. The topline softness was driven by continued macroeconomic pressure and a reduction in license volumes. Nevertheless, Kontigo maintained coverage in over 60% of Swedish municipalities and secured two new contracts during the quarter, highlighting resilience in a challenging market. Cost levels remained well-managed, and the company’s cash position continues to support its product roadmap and international expansion efforts. We expect only minor downward adjustments to near-term revenue forecasts.
LÄS MER
